8 out of 10 cancer patients anticipate clinical benefit from early phase trials: study

Over 80 percent of cancer patients taking part in early phase 1 clinical trials are motivated by the prospect of a clinical benefit, a UK study reports. According to the survey of over 300 patients attending a phase I trial outpatient clinic for the first time, approximately half anticipated tumour shrinkage, and approximately a tenth ...

Already a member?

Login to keep reading.

© 2021 the limbic